XTX Topco Ltd lessened its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 27.4% in the 1st quarter, according to its most recent disclosure with the SEC. The firm owned 88,917 shares of the pharmacy operator's stock after selling 33,511 shares during the period. XTX Topco Ltd's holdings in Walgreens Boots Alliance were worth $993,000 as of its most recent SEC filing.
Several other large investors have also made changes to their positions in the business. First Trust Advisors LP purchased a new stake in shares of Walgreens Boots Alliance in the fourth quarter worth about $368,000. Mirae Asset Global Investments Co. Ltd. raised its position in Walgreens Boots Alliance by 6.0% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 87,428 shares of the pharmacy operator's stock valued at $978,000 after purchasing an additional 4,926 shares during the period. Concurrent Investment Advisors LLC raised its position in Walgreens Boots Alliance by 28.2% during the first quarter. Concurrent Investment Advisors LLC now owns 13,924 shares of the pharmacy operator's stock valued at $156,000 after purchasing an additional 3,064 shares during the period. Teacher Retirement System of Texas purchased a new stake in Walgreens Boots Alliance during the first quarter valued at approximately $1,199,000. Finally, Allspring Global Investments Holdings LLC raised its position in Walgreens Boots Alliance by 3.3% during the first quarter. Allspring Global Investments Holdings LLC now owns 42,332 shares of the pharmacy operator's stock valued at $472,000 after purchasing an additional 1,341 shares during the period. 58.59% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
WBA has been the topic of a number of recent research reports. UBS Group restated a "neutral" rating on shares of Walgreens Boots Alliance in a research report on Thursday, June 26th. Wall Street Zen began coverage on Walgreens Boots Alliance in a research report on Wednesday, May 21st. They set a "hold" rating on the stock. Finally, Morgan Stanley reaffirmed an "underweight" rating on shares of Walgreens Boots Alliance in a research note on Thursday, June 26th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Walgreens Boots Alliance presently has an average rating of "Hold" and a consensus price target of $10.59.
Read Our Latest Research Report on Walgreens Boots Alliance
Walgreens Boots Alliance Stock Up 0.3%
NASDAQ WBA traded up $0.03 during midday trading on Tuesday, hitting $11.69. 4,120,096 shares of the company traded hands, compared to its average volume of 5,726,707. The company's 50-day simple moving average is $11.44 and its 200-day simple moving average is $11.09. The company has a debt-to-equity ratio of 0.96, a current ratio of 0.60 and a quick ratio of 0.32. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $13.25. The company has a market cap of $10.12 billion, a PE ratio of -1.60, a price-to-earnings-growth ratio of 1.37 and a beta of 0.80.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings data on Thursday, June 26th. The pharmacy operator reported $0.38 earnings per share for the quarter, beating analysts' consensus estimates of $0.34 by $0.04. The business had revenue of $38.99 billion during the quarter, compared to analyst estimates of $36.72 billion. Walgreens Boots Alliance had a positive return on equity of 17.66% and a negative net margin of 4.07%. The company's revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the business posted $0.63 EPS. As a group, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.
Walgreens Boots Alliance Company Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Stories

Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.